Kura Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	39.08	149.1	224.46	37.32	51.8	90.67
Short-Term Investments	541.74	518.14	502.93	386.64	386.18	427.29
Cash & Short-Term Investments	580.82	667.24	727.4	423.96	437.99	517.96
Cash Growth	-11.76%	-8.27%	71.57%	-3.20%	-15.44%	-18.21%
Accounts Receivable	9.35	8.8	2.06	-	-	-
Inventory	0.84	0.41	-	-	-	-
Other Current Assets	32.77	32.21	15.37	8.52	8.44	4.33
Total Current Assets	623.78	708.66	744.83	432.48	446.43	522.29
Net Property, Plant & Equipment	14.78	15.16	7.49	8.68	6.38	8.25
Other Long-Term Assets	13.99	14.54	7.85	7.6	3.5	3.52
Total Assets	652.55	738.36	760.16	448.94	456.31	534.05
Accounts Payable	7.04	5.02	1.47	33.76	21.74	20.19
Accrued Expenses	45.47	61.7	48.48	-	-	-
Current Portion of Long-Term Debt	-	-	2.61	-	-	-
Current Portion of Leases	1.28	1.28	1.88	1.51	2.32	2.26
Unearned Revenue	47.7	48.98	24.27	-	-	-
Total Current Liabilities	101.5	116.97	78.71	35.26	24.06	22.46
Long-Term Debt	9.75	9.71	6.92	9.33	9.16	-
Long-Term Leases	13.24	9.47	5.19	6.36	2.55	4.61
Other Long-Term Liabilities	420.18	428.07	255.7	0.71	0.27	0.38
Total Long-Term Liabilities	443.17	447.25	267.81	16.4	11.97	4.99
Total Liabilities	544.67	564.23	346.52	51.66	36.03	27.44
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,356	1,347	1,308	1,120	997.11	941.36
Accumulated Other Comprehensive Income	-0.38	1.02	0.76	-1.27	-8.03	-1.79
Retained Earnings	-1,247	-1,174	-895.42	-721.44	-568.81	-432.97
Shareholders' Equity	107.88	174.14	413.64	397.27	420.28	506.61
Total Liabilities & Equity	652.55	738.36	760.16	448.94	456.31	534.05
Total Debt	24.27	20.46	16.59	17.2	14.02	6.88
Net Cash (Debt)	556.55	646.78	710.8	406.76	423.96	511.09
Net Cash Growth	-13.95%	-9.01%	74.75%	-4.06%	-17.05%	-17.62%
Net Cash Per Share	6.33	7.38	8.25	5.55	6.33	7.70
Book Value	107.88	174.14	413.64	397.27	420.28	506.61
Book Value Per Share	1.23	1.99	4.80	5.43	6.27	7.64
Tangible Book Value	107.88	174.14	413.64	397.27	420.28	506.61
Tangible Book Value Per Share	1.23	1.99	4.80	5.43	6.27	7.64

SEC Filings: 10-K · 10-Q